Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

Kaiser Daily Global Health Policy ReportVaccines Search Results « » The Henry J. Kaiser Family Foundation

Vaccines

  • your selections
Clear Search

Filter Results

date

Tags

  • results
GAVI Needs Strategic Plan For Future, CSIS Report Says

In this report from the Center for Strategic and International Studies, released ahead of the GAVI Alliance pledging conference, authors Lisa Carty, J. Stephen Morrison, Margaret Reeves, and Amanda Glassman write, “Its many achievements notwithstanding, GAVI still needs a strategic approach in the coming years if it is to deepen…

GSK, Crucell To Test Second-Generation Malaria Vaccine

GlaxoSmithKline and drug company Crucell, a division of Johnson & Johnson, will collaborate with the PATH Malaria Vaccine Initiative to test a second-generation malaria vaccine “within the next couple of months,” Reuters reports.

U.S. Must Provide Ample Funding For GAVI

“Considering its wealth, the U.S. spends relatively little on humanitarian aid that can make an enormous difference in the lives of millions of people – and in the perception of the U.S. around the world. Nothing this nation could do with $450 million would surpass the good accomplished with a vaccination pledge to GAVI,” according to a Detroit Free Press editorial, which calls for President Barack Obama to provide $450 million over three years for the GAVI Alliance (6/1).

Appointment Of Drug Company To GAVI Board Draws Criticism From NGOs

The appointment of Dutch pharmaceutical company Crucell, recently acquired by Johnson & Johnson, to the board of the GAVI Alliance is “sparking concerns over conflicts of interest and demands for tougher competition to reduce prices,” the Financial Times reports.

Recent Releases In Global Health

Where Is Global Health On The G8 Agenda?: As the G8 summit began in Deauville, France, on Thursday, David Olson, the council’s director of policy communications, wrote on the Global Health Council’s “Blog 4 Global Health” that “global health is nowhere visible on the agenda,” which “is in striking contrast to…

Nature Special Issue Focuses On Vaccines

The May 26 issue of Nature explores vaccines, which the journal says “are responsible for some of the world’s greatest public health triumphs.” Though new vaccines for deadly diseases have been developed in the past 10 years, and more are in development, “funding is tight, and unfounded doubts about the safety of vaccines persist.” The issue features stories on polio, measles, HIV/AIDS, tuberculosis and malaria, as well as issues surrounding vaccine rejection and hysteria about risk (5/26).